NCT05627180

Brief Summary

Health literacy refers to personal and relational factors affecting a persons ability to aquire, understand and use health information and health services. In a need assessment study, it was found that there is a need to focus on health literacy factors in the follow-up of people with cancer in the health care services. Thus, this project evaluate the effect of a health literacy intervention in cancer. The intervention provides patients with nurse-led tailored follow-up by phone/digital/personal meetings that addresses their individual HL needs, particularly those needs that impact their quality of life, symptom burden, self-management, and health economic costs. Our main goal is to improve the patients' health literacy, with secondary goals of improving their quality of life, symptom burden, and self-management, and reducing their health care costs.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P50-P75 for not_applicable cancer

Timeline
8mo left

Started Mar 2023

Longer than P75 for not_applicable cancer

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress83%
Mar 2023Dec 2026

First Submitted

Initial submission to the registry

November 10, 2022

Completed
15 days until next milestone

First Posted

Study publicly available on registry

November 25, 2022

Completed
4 months until next milestone

Study Start

First participant enrolled

March 30, 2023

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Expected
Last Updated

April 3, 2023

Status Verified

March 1, 2023

Enrollment Period

1.8 years

First QC Date

November 10, 2022

Last Update Submit

March 30, 2023

Conditions

Keywords

Health literacy

Outcome Measures

Primary Outcomes (1)

  • General Health literacy measured with the Health Literacy Questionnaire (HLQ)

    Change of Health Literacy questionnaire

    6 months, 9 months

Secondary Outcomes (8)

  • Electronic Health Literacy measured with the electronic Health Literacy Questionnaire (eHLQ)

    6 months, 9 months

  • General symptoms measured with the Edmonton Symptom Assessment System (ESAS)

    6 months, 9 months

  • Oral symptoms measured with four items selected from the European Organization for REsearch and Treatment of Cancer-oral health 15 (EORTC-OH 15)

    6 months, 9 months

  • Self-management measured with the Health Education Impact Questionnaire (HeiQ)

    6 months, 9 months

  • Self-Efficacy measured with the General Self-efficacy Scale (GSE)

    6 months, 9 months

  • +3 more secondary outcomes

Study Arms (2)

The Intervention Group

EXPERIMENTAL

The intervention group will receive a tailored intervention based on each individuals health literacy needs. A project nurse with broad experience in cancer care will be trained in Motivational Interviewing techniques to provide follow-up for the patients in the intervention group in a period of 9 months.

Behavioral: Tailored Health Literacy follow-up in cancer

Usual care group

NO INTERVENTION

Usual care group will receive usual follow-up.

Interventions

1. Participants are invited to a consultation with the project nurse where the project nurse will use baseline data to identify the patient's HL needs, QOL, symptom burden and issues related to self-management of their cancer and treatment. These data will be used together with an interview questionnaire specifically developed to communicate HL needs (i.e. CHAT), which form the basis for the individualized HL support. 2. Actions: Based on results of the consultation, the project nurse and the patient will use a worksheet of possible actions to identify those most relevant to the patient's individual needs. Based on this, different self-management tasks and actions will be offered, and an individual tailored follow-up plan will be made. The patient and the project nurse will use a workbook containing information on the follow-up plan that will be added into medical record. 3. Telephone/digital conversations with the project every second month for a period of 9 months.

The Intervention Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosed with cancer
  • Above 18 years old
  • Receiving treatment at the main intervention hospital

You may not qualify if:

  • Not diagnosed with cancer
  • Not above 18 years old
  • Not in treatment at the intervention hospital

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Lovisenberg Diakonale Hospital

Oslo, 0440, Norway

RECRUITING

MeSH Terms

Conditions

Neoplasms

Study Officials

  • Christine R Borge, PhD

    Lovisenberg Diaconal Hospital and University of Oslo

    PRINCIPAL INVESTIGATOR
  • Astrid K Wahl, PhD

    University of Oslo

    STUDY CHAIR
  • Simen A Steindal, PhD

    VID

    STUDY CHAIR

Central Study Contacts

Christine R Borge, PhD

CONTACT

Marit Leine, master

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Masking Details
The main researcher and PhD candidate will be blinded to the randomizing procedure. However, in this project, it is not feasible to blind the participants, HCPs or PhD candidate to the participants' group. The participants will be randomized right after the first assessment.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Randomized controlled trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Researcher

Study Record Dates

First Submitted

November 10, 2022

First Posted

November 25, 2022

Study Start

March 30, 2023

Primary Completion

December 31, 2024

Study Completion (Estimated)

December 31, 2026

Last Updated

April 3, 2023

Record last verified: 2023-03

Data Sharing

IPD Sharing
Will not share

Locations